Skip to content
  • Reports
  • Podcast
  • Log In

Now covering the global biotech industry!
Read More
Topics
  • CRISPR
  • CAR-T
  • Covid-19
  • Microbiome
  • mRNA technology
  • Gene therapy
  • CRISPR
  • CAR-T
  • Covid-19
  • Microbiome
  • mRNA technology
  • Gene therapy
  • Log In
Now covering the global biotech industry!
Read More

Home » What’s new » Novartis

Novartis

ADVERTISEMENT
In Depth

A Cure for Cancer? How CAR-T Cell Therapy is Revolutionizing Oncology

CAR-T therapy has been hailed as a cure for cancer, but what really is this…

By Clara Rodríguez Fernández
11/10/2021 - 10 minutes
Best in Biotech

Needle-Free Diabetes Care: 7 Devices that Painlessly Monitor Blood Sugar

Will the daily routine of finger pricking to monitor blood sugar levels finally come to…

By Clara Rodríguez Fernández
28/09/2021 - 6 minutes
News and Trends

British Diagnostics Biotech Becomes Social Enterprise After Acquisition

UK rapid diagnostics company Mologic will convert into a social enterprise after being acquired by…

By Anita Chakraverty
30/07/2021 - 4 minutes
News and Trends

EMA Approvals for Multiple Sclerosis Highlight Treatment Shortfalls

While the EU saw rapid-fire approvals in the multiple sclerosis space last month, the innovations…

By Jonathan Smith
27/04/2021 - 6 minutes
News and Trends

Radiopharmaceuticals Gain Traction for Cancer Theranostics Potential

After decades of neglect from big pharma, radiopharmaceuticals are generating major oncology deals globally. This…

By Jonathan Smith
06/11/2020 - 6 minutes
News and Trends

Update: Novartis’ Gene Therapy Zolgensma Gets Nod from EU

Update (19/05/2020): The gene therapy Zolgensma, developed by the big pharma Novartis and approved in…

By Jonathan Smith
19/05/2020 - 5 minutes
News and Trends

Update: FDA Imposes No Penalties for Novartis Data Manipulation Scandal

Update (02/04/2020): The FDA has concluded an investigation into a data manipulation scandal surrounding the…

By Jonathan Smith
02/04/2020 - 3 minutes
News and Trends

Novartis Enters RNA Therapeutics with Medicines Company Merger

Novartis is to acquire The Medicines Company and its late-stage RNA interference drug designed to…

By Jonathan Smith
25/11/2019 - 3 minutes
News and Trends

European Project Launches to Tailor Autoimmune Disease Treatments

Public and private organizations across Europe will pool their resources in an €80M project to…

By Jonathan Smith
31/10/2019 - 2 minutes
News and Trends

Trial Testing Spinal Application of Zolgensma Put on Hold by FDA

The FDA has placed a partial hold on clinical trials testing a new application method…

By Jonathan Smith
30/10/2019 - 2 minutes
News and Trends

MorphoSys and Galapagos’ Eczema Drug Abandoned at Phase II

Development of MorphoSys, Galapagos, and Novartis’ first-in-class antibody drug has been discontinued during a phase…

By Jonathan Smith
29/10/2019 - 2 minutes
News and Trends

Top Cardiology Biotech News from the ESC Conference 2019

Many cardiology companies and academics gathered in Paris earlier this week to showcase their latest…

By Jonathan Smith
05/09/2019 - 4 minutes
  • 1
  • 2
  • 3
  • …
  • 8
  • Next Page »
footer logo

Labiotech.eu is the leading digital media covering the global biotech industry.

Over 150,000 monthly visitors use it to keep an eye on the business and innovations in biotechnology. Hope you’ll enjoy reading our stories!

  • About us
  • Inside Labiotech
  • Join Us
  • Advertise
  • Contact
  • Editorial Calendar
  • Site Map
  • Linkedin
  • Twitter
  • Youtube
  • RSS Feed
Made with in Berlin. Labiotech UG, All Rights Reserved -
  • Imprint
  • Privacy Policy

Browse Topics

Search for a topic, country or company name by using the search box

    Popular topics:


    CRISPR mRNA technology CAR-T HIV Cell therapy Diabetes Microbiome Startups Gene therapy Synthetic biology
    Labiotech.eu
    Log In Newsletter

    Topics

    • Gene Therapy
    • CRISPR
    • CAR-T
    • Covid-19
    • Microbiome
    • Diabetes
    • Cancer

    Sections

    • News and Trends
    • In Depth
    • Best in Biotech
    • Opinion
    • Interview
    • Infographics
    Show All Topics

    For Members

    • Expert Advice
    • Reports
    • Startup Scout

    More

    • About us
    • Inside Labiotech
    • Join Us
    • Advertise
    • Contact
    • Podcast